Gulf Pharmaceutical Industries PSC (JULPHAR) - Financial and Strategic SWOT Analysis Review

Date: February 22, 2017
Pages: 44
Price:
US$ 125.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: GFC68D4975CEN
Leaflet:

Download PDF Leaflet

Gulf Pharmaceutical Industries PSC (JULPHAR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Gulf Pharmaceutical Industries PSC (Julphar) is a pharmaceutical company which undertakes the manufacture and distribution of medicines. It is one of the largest pharmaceutical distributors in the Middle East and North Africa (MENA) region. The company's product portfolio consists of antibiotics, cough and cold preparations, ulcer-healing agents, cardiovascular products, biotech, dermatology, insulin, over-the-counter, GIT, metabolic and paramedical products, women’s health, pulmonary, wound and burn, and other products. The company has manufacturing facilities in Ras Al Khaimah and Ethiopia. It has direct offices in Asia, Middle East and Africa. Julphar has 40 gloal offices and is headquartered in Digdaga, Ras Al Khaimah, the UAE.

Gulf Pharmaceutical Industries PSC Key Recent Developments

Jan 29, 2017: Julphar CEO leaves the company after 8 years of service
Jan 09, 2017: Julphar appoints new CFO
Nov 20, 2016: Julphar reports first nine months earnings
Aug 14, 2016: Julphar reports first half earnings: H1 sales of AED 759.7 million with a net profit of AED 133.8 million
Jun 16, 2016: Julphar Bangladesh receives international ISO certification during World Accreditation Day

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers. - The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

    Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

    Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

    Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

    Note: Some sections may be missing if data is unavailable for the company
  • SECTION 1 - ABOUT THE COMPANY

    Gulf Pharmaceutical Industries PSC - Key Facts
    Gulf Pharmaceutical Industries PSC - Key Employees
    Gulf Pharmaceutical Industries PSC - Key Employee Biographies
    Gulf Pharmaceutical Industries PSC - Major Products and Services
    Gulf Pharmaceutical Industries PSC - History
    Gulf Pharmaceutical Industries PSC - Locations And Subsidiaries
    Head Office
    Other Locations & Subsidiaries
    Joint Venture

    SECTION 2 – COMPANY ANALYSIS

    Gulf Pharmaceutical Industries PSC - Business Description
    Gulf Pharmaceutical Industries PSC - Corporate Strategy
    Gulf Pharmaceutical Industries PSC - SWOT Analysis
    SWOT Analysis - Overview
    Gulf Pharmaceutical Industries PSC - Strengths
    Gulf Pharmaceutical Industries PSC - Weaknesses
    Gulf Pharmaceutical Industries PSC - Opportunities
    Gulf Pharmaceutical Industries PSC - Threats
    Gulf Pharmaceutical Industries PSC - Key Competitors

    SECTION 3 – COMPANY FINANCIAL RATIOS

    Financial Ratios - Capital Market Ratios
    Financial Ratios - Annual Ratios
    Performance Chart
    Financial Performance
    Financial Ratios - Interim Ratios
    Financial Ratios - Ratio Charts

    SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

    Gulf Pharmaceutical Industries PSC, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
    Gulf Pharmaceutical Industries PSC, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
    Gulf Pharmaceutical Industries PSC, Recent Deals Summary

    SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

    Jan 29, 2017: Julphar CEO leaves the company after 8 years of service
    Jan 09, 2017: Julphar appoints new CFO
    Nov 20, 2016: Julphar reports first nine months earnings
    Aug 14, 2016: Julphar reports first half earnings: H1 sales of AED 759.7 million with a net profit of AED 133.8 million
    Jun 16, 2016: Julphar Bangladesh receives international ISO certification during World Accreditation Day
    May 25, 2016: Julphar reports first quarter earnings - Q1 sales of AED 370 million with a net profit of AED 79 million
    May 23, 2016: Julphar Bangladesh collaborates to improve availability of high quality medicines in Bangladesh
    Apr 11, 2016: Julphar announces full year 2015 financial results: 6% sales growth with net profit of AED 226 million

    SECTION 6 – APPENDIX

    Methodology
    Ratio Definitions
    About GlobalData
    Contact Us
    Disclaimer

    LIST OF TABLES

    Gulf Pharmaceutical Industries PSC, Key Facts
    Gulf Pharmaceutical Industries PSC, Key Employees
    Gulf Pharmaceutical Industries PSC, Key Employee Biographies
    Gulf Pharmaceutical Industries PSC, Major Products and Services
    Gulf Pharmaceutical Industries PSC, History
    Gulf Pharmaceutical Industries PSC, Other Locations
    Gulf Pharmaceutical Industries PSC, Subsidiaries
    Gulf Pharmaceutical Industries PSC, Joint Venture
    Gulf Pharmaceutical Industries PSC, Key Competitors
    Gulf Pharmaceutical Industries PSC, Ratios based on current share price
    Gulf Pharmaceutical Industries PSC, Annual Ratios
    Gulf Pharmaceutical Industries PSC (Cont...1), Annual Ratios
    Gulf Pharmaceutical Industries PSC, Interim Ratios
    Gulf Pharmaceutical Industries PSC, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
    Gulf Pharmaceutical Industries PSC, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
    Gulf Pharmaceutical Industries PSC, Recent Deals Summary
    Currency Codes
    Capital Market Ratios
    Equity Ratios
    Profitability Ratios
    Cost Ratios
    Liquidity Ratios
    Leverage Ratios
    Efficiency Ratios

    LIST OF FIGURES

    Gulf Pharmaceutical Industries PSC, Performance Chart (2011 - 2015)
    Gulf Pharmaceutical Industries PSC, Ratio Charts
    Gulf Pharmaceutical Industries PSC, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
    Gulf Pharmaceutical Industries PSC, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017
    Skip to top


    Ask Your Question

    Gulf Pharmaceutical Industries PSC (JULPHAR) - Financial and Strategic SWOT Analysis Review
    Company name*:
    Contact person*:
    Phone/fax*:
    Email*:
    Request invoice
    Your enquiry:
    Please click on a Check Box below to confirm you are not a robot: